🇺🇸 FDA
Patent

US 8686041

Inhibition of ornithine aminotransferase for the treatment of proliferative disorders

granted A61KA61K31/196A61K31/198

Quick answer

US patent 8686041 (Inhibition of ornithine aminotransferase for the treatment of proliferative disorders) held by Northwestern University expires Mon Mar 27 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Northwestern University
Grant date
Tue Apr 01 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 27 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
6
CPC classes
A61K, A61K31/196, A61K31/198, A61P, A61P35/00